PDSB · PDS Biotechnology Corp · Share Buybacks
$0.31
+0.01 (+4.91%)
At close · Sep 10
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result of these uncertainties, the Company has concluded that substantial doubt exists about the Company's ability to continue as a going concern for a period of at least 12 months from the date of the issuance of these unaudited Condensed Consolidated Financial Statements.”View the 10-Q filed Aug 13, 2026
Market Cap
$16.40M
Shares
55.97M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2022-08 | — | $50,000,000 | — | — | 10-K , filed 2026-03-30 |
Key facts
CIK
1472091
CUSIP
70465T107
13F (30d)
38 filings
38 filers
Visit website
Investor relations